Cargando…
Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
Minimally invasive detection of circulating tumor DNA (ctDNA) in peripheral blood or other body fluids of patients with gastrointestinal malignancies via liquid biopsy has emerged as a promising biomarker. This is urgently needed, as conventional imaging and plasma protein-derived biomarkers lack se...
Autores principales: | Kirchweger, Patrick, Wundsam, Helwig Valentin, Rumpold, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244970/ https://www.ncbi.nlm.nih.gov/pubmed/35949436 http://dx.doi.org/10.5306/wjco.v13.i6.473 |
Ejemplares similares
-
Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer
por: Kirchweger, Patrick, et al.
Publicado: (2022) -
Data of ‘Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage’
por: Kirchweger, Patrick, et al.
Publicado: (2022) -
Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2023) -
Prospects of conservative treatment for Clostridium septicum–associated aortitis
por: Kirchweger, Patrick, et al.
Publicado: (2022) -
Endoscopic Transmural Therapy of Pancreatic Fistulas in an Interdisciplinary Setting—A Retrospective Data Analysis
por: Meierhofer, Clara, et al.
Publicado: (2023)